this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 21 citations 1 artifacts 2026-05-30T16:14:23.302760

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Functional Annotation of Edem2 (Drosophila melanogaster)

0) Target verification (critical disambiguation)

The literature surveyed consistently identifies Drosophila melanogaster Edem2 as CG5682 (also called dEDEM2), an ER protein quality-control factor homologous to mammalian EDEM proteins and yeast Htm1p, aligning with the UniProt-provided accession Q9VK27 (alpha-1,2-mannosidase-like; GH47 family). (kang2009suppressionofretinal pages 3-4)

1) Key concepts and definitions (current understanding)

1.1 ER-associated degradation (ERAD) and glycoprotein ERAD (gpERAD)

ER-associated degradation (ERAD) is a conserved pathway that recognizes misfolded proteins in the endoplasmic reticulum (ER), retrotranslocates them to the cytosol, and targets them for proteasomal degradation. In the case of glycoprotein ERAD (gpERAD), progressive trimming of high-mannose N-glycans helps “time” folding attempts and creates glycan signals that promote commitment of terminally misfolded clients to ERAD. In mammalian systems, recent mechanistic syntheses place EDEM2 as the factor catalyzing the first mannose-trimming step that initiates gpERAD, with later steps involving other EDEM-family members. (ninagawa2024uggt1mediatedreglucosylationof pages 20-22)

1.2 EDEM proteins and “α-mannosidase-like” activity

EDEM proteins (ER degradation-enhancing α-mannosidase-like proteins) are class I α-mannosidase-like factors (GH47-related) implicated in accelerating disposal of misfolded glycoproteins. Biochemically, mammalian EDEM1/EDEM2 show bona fide mannosidase activity in vitro, but with substrate folding-state dependence: activity is modest on free glycans/native glycoproteins and substantially higher on denatured/unfolded glycoproteins, consistent with selective action on misfolded ER clients. (shenkman2018mannosidaseactivityof pages 1-2, shenkman2018mannosidaseactivityof pages 4-5)

2) Gene product function: what Edem2 does in Drosophila

2.1 Primary cellular role: ER proteostasis factor promoting clearance of misfolded ER clients

Multiple Drosophila studies show Edem2 functions as a misfolded-protein clearance factor in the ER that reduces levels of aberrant proteins and mitigates downstream ER stress and tissue degeneration.

Collectively, these data support Edem2 as an ER quality-control/ERAD-associated factor whose primary function is to promote disposal of misfolded ER clients, thereby improving proteostasis and organismal fitness under chronic proteotoxic burden. (kang2009suppressionofretinal pages 4-5, sekiya2017edemfunctionin pages 5-7)

2.2 Enzymatic activity and substrate specificity (direct Drosophila evidence + mechanistic inference)

Direct Drosophila functional assays show that Edem2 influences the abundance/clearance of canonical ERAD substrates:

What is the reaction and substrate? Based on family biochemistry and mammalian mechanistic work, EDEM2 is an α1,2-mannose trimming enzyme acting on high-mannose N-glycans of misfolded glycoproteins to promote gpERAD commitment; however, the Drosophila studies above primarily demonstrate functional outcomes (client reduction, stress suppression, phenotypes) rather than providing residue-level structural glycan endpoints (e.g., Man9→Man8 at a defined branch) in flies. (ninagawa2024uggt1mediatedreglucosylationof pages 20-22, sekiya2017edemfunctionin pages 5-7)

Folded-state selectivity (inference from authoritative biochemistry): In vitro mammalian experiments demonstrate EDEM2’s mannosidase activity is much higher on unfolded/denatured glycoproteins, trimming N-glycans to smaller high-mannose species (reported endpoints include M8→M5 species), consistent with selective targeting of misfolded clients rather than mature folded proteins. (shenkman2018mannosidaseactivityof pages 4-5, shenkman2018mannosidaseactivityof pages 1-2)

2.3 Mannosidase-independent (“chaperone-like”) role in some contexts

A notable finding in Drosophila is that Edem2 can protect against some forms of ER proteinopathy even when mannosidase activity is disrupted:

This indicates Edem2’s functional repertoire in vivo may include (i) mannose trimming–dependent gpERAD promotion for canonical glycoprotein ERAD clients (e.g., NHK), and (ii) mannosidase-independent client engagement that can still mitigate ER proteotoxicity in particular models. (sekiya2017edemfunctionin pages 5-7)

3) Subcellular localization (where Edem2 acts)

Across Drosophila functional studies, Edem2 activity is consistently linked to ER processes: it acts on ER luminal substrates (NHK) and on misfolded rhodopsin that induces ER stress, and its manipulations modulate ER stress readouts. This functional positioning supports Edem2 as an ER-resident/ER lumen-facing quality control factor acting upstream of ERAD commitment and disposal. (kang2009suppressionofretinal pages 4-5, sekiya2017edemfunctionin pages 5-7)

4) Pathways and biological processes involving Edem2

4.1 Photoreceptor proteostasis and retinal degeneration (ADRP-like rhodopsin proteinopathy)

In a Drosophila autosomal-dominant-retinitis-pigmentosa (ADRP) model using misfolded Rh-1G69D, Edem2 acts as a protective ER quality-control factor: it reduces mutant rhodopsin burden, suppresses ER stress reporter activation, and delays structural degeneration of the retina. (kang2009suppressionofretinal pages 4-5)

4.2 Aging and chronic ER proteinopathy

In aging flies, ERAD capacity can decline, and increasing dEDEM activity is protective in the context of chronic ER proteinopathy. Tissue-specific overexpression shows distinct outcomes depending on where proteostasis is boosted (neurons, muscle, midgut). (sekiya2017edemfunctionin pages 9-10)

4.3 Genetic interaction evidence for substrate-selective ERAD roles in photoreceptors

Hiramatsu et al. (2019) used Edem2 (Edem2DG03809) with Edem1 alleles in photoreceptor genetics to impair ERAD and test whether degradation of EMC-dependent multipass membrane proteins was ERAD-mediated. They observed that loss of Edem1/Edem2 could increase ER accumulation of certain proteins in specific genetic backgrounds (e.g., with Syx5), but did not rescue EMC3-dependent losses of Rh1/TRP, supporting the conclusion that some client degradation is ERAD-independent while other substrates remain Edem-dependent. (hiramatsu2019ermembraneprotein pages 5-9)

5) Recent developments (2023–2024 prioritized)

Direct 2023–2024 primary literature specifically interrogating Drosophila Edem2 (CG5682/Q9VK27) appears limited in the retrieved corpus. Nevertheless, high-authority 2024 work refines the conserved mechanistic model for EDEM2-family function:

6) Current applications and real-world implementations

Edem2 is currently used primarily as a functional proteostasis/ERAD lever in model systems:

  1. Disease-like proteotoxicity models in vivo:
  2. Rhodopsin misfolding/retinal degeneration (Rh-1G69D) to study ERAD modulation and photoreceptor survival. (kang2009suppressionofretinal pages 4-5)
  3. ER proteinopathy in neurons (Aβ42) to test genetic enhancement of ER quality control as a protective strategy. (sekiya2017edemfunctionin pages 5-7)

  4. ER stress / ERAD readouts and reporters:

  5. xbp1-EGFP reporter to quantify ER stress (UPR activation proxy) in eye discs under misfolded Rh1 burden and its suppression by Edem2. (kang2009suppressionofretinal pages 4-5)
  6. Canonical ERAD substrates (e.g., NHK) as molecular readouts of ERAD enhancement or impairment upon Edem2 manipulation. (sekiya2017edemfunctionin pages 5-7)

These applications are relevant to broader real-world problems in protein misfolding diseases and age-associated proteostasis decline, where ERAD modulation is a proposed intervention axis; Drosophila Edem2 provides an experimentally tractable genetic handle on this biology. (sekiya2017edemfunctionin pages 9-10, kang2009suppressionofretinal pages 4-5)

7) Expert interpretation and synthesis (what authoritative sources imply)

  1. Edem2 is best interpreted as a substrate-selective ER quality control factor rather than a general UPR activator. In vivo, Edem2 manipulations can strongly suppress ER stress readouts driven by misfolded Rh1, consistent with reducing misfolded client burden upstream rather than merely altering stress signaling. (kang2009suppressionofretinal pages 4-5)

  2. Edem2 likely contributes to gpERAD both through enzymatic demannosylation and through client engagement. Drosophila evidence indicates mannosidase catalytic residues are important for clearance of at least some glycoprotein ERAD clients (NHK), while other protective effects (notably Aβ42-associated) can persist even with catalytic mutants, implying additional non-enzymatic roles. (sekiya2017edemfunctionin pages 5-7, sekiya2017edemfunctionin pages 9-10)

  3. Conserved mechanism suggests Edem2 may act early in the ERAD commitment process. Mammalian mechanistic framing (2024 synthesis) places EDEM2 at the first mannose-trimming step of gpERAD; while branch/residue-level specificity has not been demonstrated directly in the cited Drosophila studies here, the strong homology and conserved ERAD phenotypes make this the most parsimonious mechanistic hypothesis for the Drosophila protein. (ninagawa2024uggt1mediatedreglucosylationof pages 20-22, kang2009suppressionofretinal pages 3-4)

8) Key quantitative statistics (from primary studies)

9) Consolidated evidence table

Evidence type Key finding Experimental system Quantitative/statistical details Interpretation for Edem2 function Source (short citation) URL
Genetic/biochemical/phenotype Identity verified: Drosophila Edem2 = CG5682; homologous to mammalian EDEM2/EDEM3 and yeast Htm1p; belongs to GH47/class I α-mannosidase-like ERAD factors Drosophila sequence comparison and ERAD functional assays in eye disc/S2 cell models Homology-based assignment; no direct kinetic value reported in this excerpt (kang2009suppressionofretinal pages 3-4) Supports that Q9VK27 is the correct D. melanogaster Edem2 and that its expected core role is glycoprotein quality control in ERAD Kang 2009 PNAS https://doi.org/10.1073/pnas.0905566106
Biochemical Edem2 overexpression selectively reduces misfolded Rh-1G69D, but not wild-type Rh-1; also downregulates luminal ERAD substrate α1-antitrypsin NHK Drosophila larval eye imaginal discs; S2 cells; transgenic overexpression Rh-1G69D reduction quantified with n=6; NHK reduction qualitative in excerpt (kang2009suppressionofretinal pages 4-5, kang2009suppressionofretinal pages 3-4) Edem2 acts on misfolded ER clients, including both membrane and luminal substrates, consistent with a substrate-selective ERAD factor Kang 2009 PNAS https://doi.org/10.1073/pnas.0905566106
Biochemical Edem2 physically co-immunoprecipitates with Rh-1G69D but not Rh-1WT Drosophila S2 cell co-IP Interaction is substrate-selective; quantitative binding constants not reported (kang2009suppressionofretinal pages 4-5, kang2009suppressionofretinal pages 3-4) Strong evidence that Edem2 preferentially recognizes aberrant conformers rather than normal Rh1 Kang 2009 PNAS https://doi.org/10.1073/pnas.0905566106
Phenotype/UPR readout Edem2 suppresses ER stress caused by Rh-1G69D, measured by xbp1-EGFP splicing reporter Drosophila eye imaginal discs xbp1-EGFP suppression n=3, P=0.0052; no suppression reported for Rh-1WT-driven signal (kang2009suppressionofretinal pages 4-5) Edem2 lowers burden of misfolded ER proteins, likely by promoting their disposal before they trigger strong UPR signaling Kang 2009 PNAS https://doi.org/10.1073/pnas.0905566106
Phenotype Edem2 delays retinal degeneration in the ADRP model ninaE^G69D/+ Adult Drosophila retina/pseudopupil and rhabdomere analyses At 28 d, 64.43 ± 11.11% retained intact pseudopupils with Edem2 vs ~10.47 ± 8.46% lacZ control; n=4, P=0.0002. Ommatidia retaining all 7 rhabdomeres: 68.9 ± 16.1%, n=3 (kang2009suppressionofretinal pages 4-5) In vivo evidence that increasing Edem2-mediated ER quality control is protective against chronic rhodopsin proteotoxicity Kang 2009 PNAS https://doi.org/10.1073/pnas.0905566106
Genetic/biochemical Wild-type dEDEM2 reduces steady-state NHK levels, whereas catalytic mutant E144Q increases NHK levels Drosophila neuronal overexpression assays with ERAD substrate NHK Significant effects reported; exact fold-change not included in excerpt (sekiya2017edemfunctionin pages 5-7) Indicates mannosidase activity contributes to glycoprotein ERAD substrate clearance by dEDEM2 Sekiya 2017 Dev Cell https://doi.org/10.1016/j.devcel.2017.05.019
Biochemical/phenotype dEDEM2 lowers Aβ42 levels and suppresses Aβ42-induced locomotor and neurodegenerative phenotypes; catalytically inactive mutants retain protection Drosophila neuronal Aβ42 ER proteinopathy model; co-IP with Aβ42 Protective effects significant; exact behavioral values not in excerpt. Catalytic mutants E123Q/E144Q still reduced Aβ42 and protected (sekiya2017edemfunctionin pages 5-7) Suggests dEDEM2 has both mannosidase-dependent ERAD activity (for glycoproteins like NHK) and mannosidase-independent/chaperone-like activity for some nonglycosylated toxic ER proteins Sekiya 2017 Dev Cell https://doi.org/10.1016/j.devcel.2017.05.019
Phenotype/aging dEDEM2 overexpression improves age-associated physiology; neuronal overexpression modestly extends lifespan, gut overexpression extends lifespan more strongly Adult Drosophila overexpression in neurons, muscle, and midgut Neuronal median lifespan 47 → 50 d; muscle 67 → 64 d; midgut 67 → 76 d. Locomotor benefits significant; lifespan by log-rank, sample sizes ~n=190–306 depending on assay (sekiya2017edemfunctionin pages 9-10, sekiya2017edemfunctionin pages 10-12) Boosting Edem2-linked ERAD capacity can improve organismal proteostasis during aging, with tissue-specific benefit Sekiya 2017 Dev Cell https://doi.org/10.1016/j.devcel.2017.05.019
Mechanistic/UPR Chronic dEDEM overexpression protects without broad canonical UPR activation; aging is associated with slower ERAD substrate turnover Adult Drosophila brains Aging slows NHK degradation and causes CD3d-YFP accumulation; overexpression had minimal PERK/Xbp1-RB induction in excerpt (sekiya2017edemfunctionin pages 9-10, sekiya2017edemfunctionin pages 7-9) Supports Edem2 as an ERAD enhancer, not simply a general UPR activator Sekiya 2017 Dev Cell https://doi.org/10.1016/j.devcel.2017.05.019
Genetic Loss of Edem1/Edem2 contributes to stabilization of some ERAD substrates in photoreceptors, but does not rescue EMC-dependent Rh1/TRP loss Drosophila photoreceptors; Edem1/Edem2 alleles combined with Syx5 or EMC3 mutants TRP accumulation ratio: Syx5 single 0.95 ± 0.25 vs Syx5, Edem1, Edem2 triple 1.64 ± 0.30. EMC3Δ6 TRP ratio: 0.42 ± 0.05 vs 0.46 ± 0.08 in triple mutant (hiramatsu2019ermembraneprotein pages 5-9) Edem2 participates in photoreceptor ERAD, but some client degradation in EMC-deficient cells is ERAD-independent, refining substrate scope Hiramatsu 2019 Mol Biol Cell https://doi.org/10.1091/mbc.e19-08-0434
Genetic/substrate specificity In EMC3-deficient photoreceptors, Edem1/Edem2 loss allows NaKβ accumulation but not rescue of Rh1, NaKα, or TRP Drosophila photoreceptor genetics Qualitative substrate selectivity; ratio values above for TRP (hiramatsu2019ermembraneprotein pages 5-9) Implies Edem2-dependent ERAD is substrate-selective, not universally responsible for degradation of all unstable photoreceptor proteins Hiramatsu 2019 Mol Biol Cell https://doi.org/10.1091/mbc.e19-08-0434
Mechanistic (mammalian context) Mammalian EDEM2 has bona fide mannosidase activity, weak on free glycans/native glycoproteins but stronger on denatured/unfolded glycoproteins; trimming can proceed from M8 to M5 In vitro mammalian biochemistry with recombinant proteins and glycan analysis ERManI trimmed free glycans about 3-fold more than EDEM1/EDEM2; EDEM2 interacts with PDI/TXNDC11, with ~50% stronger co-IP with TXNDC11 in excerpt (shenkman2018mannosidaseactivityof pages 4-5, shenkman2018mannosidaseactivityof pages 5-6, shenkman2018mannosidaseactivityof pages 4-4, shenkman2018mannosidaseactivityof pages 1-2) Provides conserved mechanistic context for Drosophila Edem2: likely a folding-state-sensitive GH47 α1,2-mannosidase-like ERAD factor acting preferentially on misfolded glycoproteins Shenkman 2018 Commun Biol https://doi.org/10.1038/s42003-018-0174-8
Mechanistic (mammalian context) Recent synthesis of mammalian work places EDEM2 at the first mannose-trimming step that initiates gpERAD, acting with TXNDC11 before further trimming by other EDEMs Mammalian ERAD pathway synthesis/review of primary studies No new kinetic values in excerpt; mechanistic placement cites prior primary studies (ninagawa2024uggt1mediatedreglucosylationof pages 20-22) Supports inference that Drosophila Edem2 likely functions early in glycoprotein ERAD by generating/advancing the demannosylation signal on terminally misfolded clients Ninagawa 2024 eLife https://doi.org/10.1101/2023.10.18.562958

Table: This table compiles the most relevant experimental and mechanistic findings for Drosophila Edem2/CG5682, emphasizing direct Drosophila evidence and clearly separating mammalian EDEM2 context used for functional inference.

10) Primary source list with publication dates and URLs (most relevant)

References

  1. (kang2009suppressionofretinal pages 3-4): Min-Ji Kang and Hyung Don Ryoo. Suppression of retinal degeneration in drosophila by stimulation of er-associated degradation. Proceedings of the National Academy of Sciences, 106:17043-17048, Oct 2009. URL: https://doi.org/10.1073/pnas.0905566106, doi:10.1073/pnas.0905566106. This article has 110 citations and is from a highest quality peer-reviewed journal.

  2. (ninagawa2024uggt1mediatedreglucosylationof pages 20-22): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 7 citations and is from a domain leading peer-reviewed journal.

  3. (shenkman2018mannosidaseactivityof pages 1-2): Marina Shenkman, Efrat Ron, Rivka Yehuda, Ron Benyair, Isam Khalaila, and Gerardo Z. Lederkremer. Mannosidase activity of edem1 and edem2 depends on an unfolded state of their glycoprotein substrates. Communications Biology, Oct 2018. URL: https://doi.org/10.1038/s42003-018-0174-8, doi:10.1038/s42003-018-0174-8. This article has 71 citations and is from a peer-reviewed journal.

  4. (shenkman2018mannosidaseactivityof pages 4-5): Marina Shenkman, Efrat Ron, Rivka Yehuda, Ron Benyair, Isam Khalaila, and Gerardo Z. Lederkremer. Mannosidase activity of edem1 and edem2 depends on an unfolded state of their glycoprotein substrates. Communications Biology, Oct 2018. URL: https://doi.org/10.1038/s42003-018-0174-8, doi:10.1038/s42003-018-0174-8. This article has 71 citations and is from a peer-reviewed journal.

  5. (kang2009suppressionofretinal pages 4-5): Min-Ji Kang and Hyung Don Ryoo. Suppression of retinal degeneration in drosophila by stimulation of er-associated degradation. Proceedings of the National Academy of Sciences, 106:17043-17048, Oct 2009. URL: https://doi.org/10.1073/pnas.0905566106, doi:10.1073/pnas.0905566106. This article has 110 citations and is from a highest quality peer-reviewed journal.

  6. (sekiya2017edemfunctionin pages 5-7): Michiko Sekiya, Akiko Maruko-Otake, Stephen Hearn, Yasufumi Sakakibara, Naoki Fujisaki, Emiko Suzuki, Kanae Ando, and Koichi M. Iijima. Edem function in erad protects against chronic er proteinopathy and age-related physiological decline in drosophila. Developmental cell, 41 6:652-664.e5, Jun 2017. URL: https://doi.org/10.1016/j.devcel.2017.05.019, doi:10.1016/j.devcel.2017.05.019. This article has 38 citations and is from a highest quality peer-reviewed journal.

  7. (sekiya2017edemfunctionin pages 9-10): Michiko Sekiya, Akiko Maruko-Otake, Stephen Hearn, Yasufumi Sakakibara, Naoki Fujisaki, Emiko Suzuki, Kanae Ando, and Koichi M. Iijima. Edem function in erad protects against chronic er proteinopathy and age-related physiological decline in drosophila. Developmental cell, 41 6:652-664.e5, Jun 2017. URL: https://doi.org/10.1016/j.devcel.2017.05.019, doi:10.1016/j.devcel.2017.05.019. This article has 38 citations and is from a highest quality peer-reviewed journal.

  8. (hiramatsu2019ermembraneprotein pages 5-9): Naoki Hiramatsu, Tatsuya Tago, Takunori Satoh, and Akiko K. Satoh. Er membrane protein complex is required for the insertions of late-synthesized transmembrane helices of rh1 in drosophila photoreceptors. Molecular Biology of the Cell, 30:2890-2900, Nov 2019. URL: https://doi.org/10.1091/mbc.e19-08-0434, doi:10.1091/mbc.e19-08-0434. This article has 17 citations and is from a domain leading peer-reviewed journal.

  9. (sekiya2017edemfunctionin pages 10-12): Michiko Sekiya, Akiko Maruko-Otake, Stephen Hearn, Yasufumi Sakakibara, Naoki Fujisaki, Emiko Suzuki, Kanae Ando, and Koichi M. Iijima. Edem function in erad protects against chronic er proteinopathy and age-related physiological decline in drosophila. Developmental cell, 41 6:652-664.e5, Jun 2017. URL: https://doi.org/10.1016/j.devcel.2017.05.019, doi:10.1016/j.devcel.2017.05.019. This article has 38 citations and is from a highest quality peer-reviewed journal.

  10. (sekiya2017edemfunctionin pages 7-9): Michiko Sekiya, Akiko Maruko-Otake, Stephen Hearn, Yasufumi Sakakibara, Naoki Fujisaki, Emiko Suzuki, Kanae Ando, and Koichi M. Iijima. Edem function in erad protects against chronic er proteinopathy and age-related physiological decline in drosophila. Developmental cell, 41 6:652-664.e5, Jun 2017. URL: https://doi.org/10.1016/j.devcel.2017.05.019, doi:10.1016/j.devcel.2017.05.019. This article has 38 citations and is from a highest quality peer-reviewed journal.

  11. (shenkman2018mannosidaseactivityof pages 5-6): Marina Shenkman, Efrat Ron, Rivka Yehuda, Ron Benyair, Isam Khalaila, and Gerardo Z. Lederkremer. Mannosidase activity of edem1 and edem2 depends on an unfolded state of their glycoprotein substrates. Communications Biology, Oct 2018. URL: https://doi.org/10.1038/s42003-018-0174-8, doi:10.1038/s42003-018-0174-8. This article has 71 citations and is from a peer-reviewed journal.

  12. (shenkman2018mannosidaseactivityof pages 4-4): Marina Shenkman, Efrat Ron, Rivka Yehuda, Ron Benyair, Isam Khalaila, and Gerardo Z. Lederkremer. Mannosidase activity of edem1 and edem2 depends on an unfolded state of their glycoprotein substrates. Communications Biology, Oct 2018. URL: https://doi.org/10.1038/s42003-018-0174-8, doi:10.1038/s42003-018-0174-8. This article has 71 citations and is from a peer-reviewed journal.

Artifacts

Citations

  1. kang2009suppressionofretinal pages 3-4
  2. sekiya2017edemfunctionin pages 5-7
  3. kang2009suppressionofretinal pages 4-5
  4. sekiya2017edemfunctionin pages 9-10
  5. hiramatsu2019ermembraneprotein pages 5-9
  6. shenkman2018mannosidaseactivityof pages 1-2
  7. shenkman2018mannosidaseactivityof pages 4-5
  8. sekiya2017edemfunctionin pages 10-12
  9. sekiya2017edemfunctionin pages 7-9
  10. shenkman2018mannosidaseactivityof pages 5-6
  11. shenkman2018mannosidaseactivityof pages 4-4
  12. https://doi.org/10.1073/pnas.0905566106
  13. https://doi.org/10.1016/j.devcel.2017.05.019
  14. https://doi.org/10.1091/mbc.e19-08-0434
  15. https://doi.org/10.1038/s42003-018-0174-8
  16. https://doi.org/10.1101/2023.10.18.562958
  17. https://doi.org/10.1073/pnas.0905566106,
  18. https://doi.org/10.1101/2023.10.18.562958,
  19. https://doi.org/10.1038/s42003-018-0174-8,
  20. https://doi.org/10.1016/j.devcel.2017.05.019,
  21. https://doi.org/10.1091/mbc.e19-08-0434,